Min Yuan

Jan 7, 2025 | nature.com | Min Yuan

AbstractTumor genomic profiling is often limited to one or two timepoints due to the invasiveness of tissue biopsies, but longitudinal profiling may provide deeper clinical insights. Using ctDNA data from IMpower150 study, we examined genetic changes in metastatic non-squamous NSCLC post-first-line immunotherapy. Mutations were most frequently detected in TP53, KRAS, SPTA1, FAT3, and LRP1B at baseline and during treatment.

Aug 9, 2024 | nature.com | Min Yuan

AbstractCirculating tumor DNA (ctDNA) provides valuable tumor-related information without invasive biopsies, yet consensus is lacking on optimal parameters for predicting clinical outcomes.

Aug 8, 2024 | mdpi.com | Jingwei Shao |Min Yuan |Yu Chen |Minghao Weng

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Jun 11, 2024 | dialnet.unirioja.es | Zheng Zhou |Min Yuan

IdiomacatalàDeutschEnglishespañoleuskarafrançaisgalegoitalianoportuguêsromână